National Institutes of Health
Submission for OMB Review; Comment Request; National 5 A Day for Better Health Follow-Up Survey SUMMARY: Under the provisions of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request to review and approve the information on collection listed below. This proposed information collection was previously published in the Federal Register on March 12, 1996, page 10001 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. The annualized cost to respondents is estimated at: $12,410. There are no Capital Costs to report. There are no Operating to Maintenance Costs to report. REQUEST FOR COMMENTS: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden to the collection of information on those who are to respond, including the use of appropriate automated, electronic, Specifically, Dr. Fossel altered nuclear magnetic resonance (NMR) data in the Multicenter Breast Trial (MCBT) such that the NMR test, purporting to detect from a patient's blood sample a predisposition toward malignancy or a relapse, appeared to be more accurate, sensitive, and specific than was actually the case. Premised on these falsely reported results, Dr. Fossel proposed in a PHS grant application that the National Cancer Institute provide funds to complete the MCBT.
Dr. Fossel has entered into a Voluntary Exclusion Agreement with ORI in which he has voluntarily agreed, for the three (3) year period beginning May 9, 1996, to exclude himself from:
(1) any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 CFR Part 76 (Debarment Regulations), and (2) serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant.
No scientific publications were required to be corrected as part of this Agreement.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Research Investigations, Office of Research Integrity, 5515 Security Lane, Suite 700, Rockville, MD 20852.
